Alder BioPharma (ALDR) Maintained At Overweight At Piper Jaffray

June 27, 2017 11:00 AM UTC Send to a Friend
Piper Jaffray Overweight Alder Biopharm (NASDAQ: ALDR) price target of $47.00Alder BioPharma (NASDAQ: ALDR)Analyst Dr. Charles Duncan comments "We continue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login